Hochschulschrift
Differentiation therapy of childhood neuroblastoma through selective inhibition of histone deacetylase 8
- Sprache
-
Englisch
- Umfang
-
107 Blätter
- Maße
-
30 cm
- Anmerkungen
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2016
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Role of histone deacetylase 11 in neuroblastoma
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Development of selective histone deacetylase 8 and 10 inhibitors : analysis of biological function and antitumor activity in childhood cancer
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Role of histone deacetylase 11 in neuroblastoma
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Development of selective histone deacetylase 8 and 10 inhibitors : analysis of biological function and antitumor activity in childhood cancer
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Role of histone deacetylase 11 in neuroblastoma
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Development of selective histone deacetylase 8 and 10 inhibitors : analysis of biological function and antitumor activity in childhood cancer
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands